Additional file 3 of Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

  • Osman Öcal (Creator)
  • Regina Schinner (Creator)
  • Kerstin Schütte (Creator)
  • Enrico N. De Toni (Creator)
  • Christian Loewe (Creator)
  • Otto van Delden (Creator)
  • Vincent Vandecaveye (Creator)
  • Bernhard Gebauer (Creator)
  • Christoph J Zech (Creator)
  • Christian Sengel (Creator)
  • Irene Bargellini (Creator)
  • Antonio Gasbarrini (Creator)
  • Bruno Sangro (Creator)
  • Maciej Pech (Creator)
  • Peter Malfertheiner (Creator)
  • Jens Ricke (Creator)
  • Max Seidensticker (Creator)

Dataset

Description

Additional file 3: Supplementary Fig. 3. Overall survival of patients with partial response according to depth of response (DpR) more or less than the median DpR. CI, confidence interval; HR, hazard ratio.
Dati resi disponibili2022
Editorefigshare

Accesso dataset

Cita questo